Apoptosis Cancer Research Results
Apoptosis, Apoptosis: Click to Expand ⟱
| Source: |
| Type: type of cell death |
Situation in which a cell actively pursues a course toward death upon receiving certain stimuli.
Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *ROS↓, *cognitive↓, TumCP↓, TumCMig↓, TumMeta↓, angioG↓, Apoptosis↑, *Inflam↓, IL1↓, IL2↓, IL4↓, IL6↓, TNF-α↓, P53↑, Akt↓, NF-kB↓, DNAdam↑, Casp↑, COX2↓, MMP9↓, CXCR4↓, VEGF↓, *SOD↑, *Catalase↑, *GPx↑, *NRF2↑,
| - |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*other↝, *other↝, *CRP↓, *eff↝, *other↑, *CXCR4↓, *IL1β↓, *IL6↓, *IL17↓, *IL18↓, *TNF-α↓, *MMP9↓, *PGE2↓, *COX1↓, *COX2↓, *PI3K↓, *Akt↓, *other↑, TumCCA↑, Apoptosis↑, ROS↑, JNK↑, TumAuto↑, Hif1a↓, BNIP3↝, HSP90↓, Fas↑, FasL↑, ETC↓, VEGF↓, angioG↓, RadioS↑, *neuroP↑, *HSP70/HSPA5↑, *ROS↓, *MMP↑, *Cyt‑c↓, *Casp3↓, *Casp9↓, *MAPK↓, *Dose⇅, *HSPs↑, BioAv↓, Dose↝,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *BioAv↓, *cardioP↑, *lipidLev↓, *RenoP↑, *TNF-α↓, *IL2↓, *PI3K↓, *Akt↓, *ROS↓, *cognitive↑, eff↑, cycD1/CCND1↓, hTERT/TERT↓, VEGF↓, p‑STAT3↓, TumMeta↓, TumCP↓, eff↑, eff↑, IL1β↓, IL6↓, NF-kB↓, ROS↑, MMP↓, Cyt‑c↑, Apoptosis↑, ER Stress↑, Ca+2↑, TET1↑, Let-7↑, Twist↓, EMT↓, TumCCA↑, Casp3↑, Casp9↑, BAX↑, HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓, SHP1↑, N-cadherin↓, E-cadherin↑, UPR↑, PERK↑, ATF4↑, eIF2α↑, RadioS↑, NOTCH1↑, NRF2↓, BioAv↑, eff↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
proCasp9↓, CDC2↓, CycB/CCNB1↓, Casp9↑, Casp3↑, Cyt‑c↑, cycA1/CCNA1↑, CDK2↓, APAF1↑, TumCCA↑, P53↑, BAX↑, VEGF↓, Bcl-2↓, Apoptosis↑, p‑Akt↓, p‑EGFR↓, p‑ERK↓, p‑STAT3↓, cardioP↑, Catalase↓, SOD↓, *BioAv↓, *antiOx↑, *ROS↓, *NO↓, *GSTs↑, *GSR↑, *SOD↑, *Catalase↑, *lipid-P↓, PI3K↓, Akt↓, CDK2↓, BNIP3↑, hTERT/TERT↓, DR5↑, Beclin-1↑, TNF-α↓, NF-kB↓, IL1↓, IL6↓, EMT↓, FAK↓, E-cadherin↑, MDM2↓, NOTCH↓, MAPK↑, Vim↓, N-cadherin↓, Snail↓, MMP2↓, Twist↓, MMP9↓, ROS↑, MMP↓, *AChE↓, *MMP↑, *Aβ↓, *neuroP↑, Trx1↑, ROS↓, *NRF2↑, NRF2↓, *BBB↑, ChemoSen↑, GutMicro↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↓, 1, NRF2↓, 2, ROS↓, 1, ROS↑, 4, SOD↓, 1, Trx1↑, 1,
Mitochondria & Bioenergetics ⓘ
CDC2↓, 1, ETC↓, 1, MMP↓, 3,
Core Metabolism/Glycolysis ⓘ
GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1,
Cell Death ⓘ
Akt↓, 2, p‑Akt↓, 1, APAF1↑, 1, Apoptosis↑, 5, BAX↑, 2, Bcl-2↓, 1, Casp↑, 2, Casp3↑, 2, Casp9↑, 2, proCasp9↓, 1, Cyt‑c↑, 2, DR5↑, 1, Fas↑, 1, FasL↑, 1, hTERT/TERT↓, 2, JNK↑, 1, MAPK↑, 1, MDM2↓, 1, p27↓, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1,
Protein Folding & ER Stress ⓘ
eIF2α↑, 1, ER Stress↑, 1, HSP90↓, 1, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, BNIP3↑, 1, BNIP3↝, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 2,
Cell Cycle & Senescence ⓘ
CDK2↓, 2, cycA1/CCNA1↑, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 2, p‑ERK↓, 1, Let-7↑, 1, mTOR↓, 1, NOTCH↓, 1, NOTCH1↑, 1, PI3K↓, 1, SHP1↑, 1, p‑STAT3↓, 2,
Migration ⓘ
Ca+2↑, 1, E-cadherin↑, 2, FAK↓, 1, MMP2↓, 1, MMP9↓, 2, N-cadherin↓, 2, Snail↓, 1, TET1↑, 1, TumCMig↓, 1, TumCP↓, 3, TumMeta↓, 2, Twist↓, 2, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, ATF4↑, 1, p‑EGFR↓, 1, Hif1a↓, 1, VEGF↓, 4,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, CXCR4↓, 1, IL1↓, 2, IL1β↓, 1, IL2↓, 1, IL4↓, 1, IL6↓, 3, NF-kB↓, 3, TNF-α↓, 2,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 2, Dose↝, 1, eff↑, 4, RadioS↑, 2,
Clinical Biomarkers ⓘ
p‑EGFR↓, 1, GutMicro↑, 1, hTERT/TERT↓, 2, IL6↓, 3,
Functional Outcomes ⓘ
AntiCan↑, 1, cardioP↑, 1, Risk↓, 1,
Total Targets: 98
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 2, GPx↑, 1, GSR↑, 1, GSTs↑, 1, lipid-P↓, 1, NRF2↑, 2, ROS↓, 5, SOD↑, 2,
Mitochondria & Bioenergetics ⓘ
Insulin↓, 1, MMP↑, 2,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, CRM↑, 1, glucose↓, 1, glyC↓, 1, lipidLev↓, 1,
Cell Death ⓘ
Akt↓, 2, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other↑, 2, other↝, 2,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1, HSPs↑, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↓, 2,
Migration ⓘ
MMP9↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 1, CRP↓, 1, CXCR4↓, 1, IL17↓, 1, IL18↓, 1, IL1β↓, 1, IL2↓, 1, IL6↓, 1, Inflam↓, 2, PGE2↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission ⓘ
AChE↓, 1,
Protein Aggregation ⓘ
AGEs↓, 1, Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 1, Dose⇅, 1, eff↝, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
CRP↓, 1, IL6↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 2, cognitive↓, 1, cognitive↑, 1, hepatoP↑, 2, neuroP↑, 5, RenoP↑, 1, toxicity↝, 1,
Total Targets: 59
Scientific Paper Hit Count for: Apoptosis, Apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:14 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page